Original articlesBreast cancerA phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer
Breast cancer
Under an Elsevier user license
open archive
Keywords
breast cancer
docetaxel
dose escalation
G-CSF
mobilisation
peripheral blood stem cells
phase II trial
toxicity
Cited by (0)
Copyright © 2004 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.